Beam Therapeutics Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -405,144.44%-810,800.00%-714.91%-427.08%-34.73%-593.06%
EBIT Margin -417,522.22%-553,166.67%-757.01%-555.61%-46.73%-654.25%
EBITDA Margin -435,055.56%-810,904.17%-714.99%-478.44%-34.28%-593.01%
Operating Margin -417,522.22%-553,166.67%-757.01%-555.61%-46.73%-654.25%
Net Margin -505,777.78%-816,120.83%-714.91%-474.54%-35.09%-593.13%
FCF Margin -469,561.11%-467,075.00%-218.11%-43.37%-48.43%-560.77%
Efficiency
Assets Average 303.89M963.07M1,408.08M1,400.71M1,281.77M
Equity Average 22.23M536.15M780.11M857.40M857.44M
Invested Capital -193.30M316.76M868.94M751.77M992.13M741.95M
Asset Utilization Ratio 0.000.050.040.270.05
Leverage & Solvency
Debt to Equity -0.040.290.050.020.010.01
Debt Ratio 0.050.160.030.010.010.01
Equity Ratio -1.290.540.560.550.670.66
Valuation
Enterprise Value 832.27M4,432.67M4,869.75M1,677.91M1,028.66M1,202.84M
Market Capitalization 924.11M4,732.34M5,429.74M2,756.04M2,218.54M2,053.58M
Return Ratios
Return on Sales -7.15%-4.33%-0.35%-5.93%
Return on Capital Employed -0.66%-0.52%-0.29%-0.15%-0.38%
Return on Assets -0.64%-0.38%-0.19%-0.09%-0.29%
Return on Equity -8.75%-0.69%-0.34%-0.15%-0.44%